Penumbra
Logotype for Penumbra Inc

Penumbra (PEN) investor relations material

Penumbra 44th Annual J.P. Morgan Healthcare Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Penumbra Inc
44th Annual J.P. Morgan Healthcare Conference summary12 Jan, 2026

Company overview and manufacturing strategy

  • Over 4,500 employees worldwide, with products available in 100+ markets; all manufacturing currently in California but expanding to a new 330,000 sq ft facility in Costa Rica by 2027, with an option for an additional 330,000 sq ft.

  • Manufacturing co-located with engineering accelerates product iteration and innovation; new facilities in Roseville and Costa Rica support future growth.

  • Headquarters in Alameda, with 260,000 sq ft in Alameda and 300,000 sq ft in Roseville.

Market opportunities and business segments

  • Total annual U.S. thrombectomy market opportunity exceeds 1,250,000 patients, including arterial, venous DVT, PE, coronary, and stroke cases.

  • Thrombectomy and embolization are both significant growth drivers, with sustainable growth in both peripheral and neuro markets.

  • Peripheral embolization procedures address 175,000 patients, with 140,000 MMAe patients annually.

  • U.S. arterial thrombectomy market has over 250,000 patients, with significant room to convert traditional treatments to mechanical solutions.

  • DVT and PE represent the largest patient opportunities, with mechanical thrombectomy penetration still low, especially in PE at around 15%.

Technology and clinical data

  • Transitioned from analog catheter/pump systems to advanced Computer-Assisted Vacuum Thrombectomy (CAVT) technology, improving outcomes and speed.

  • STORM-PE RCT showed CAVT plus anticoagulation led to a 29.7% relative reduction in right heart strain versus 8% for anticoagulation alone in acute, intermediate-high risk PE.

  • CAVT arm had comparable safety to anticoagulation, with fewer major adverse events and 100% technical success.

  • Latest product, Flash 3.0, demonstrated device times as low as one minute in clinical cases, highlighting rapid innovation.

  • Stroke interventions using RED 72 and RED 43 devices showed pre- and post-procedure improvements in M1 and M2 occlusions.

Future manufacturing capacity post-2027 expansion
CAVT's competitive advantage from STORM-PE trial
What is the growth outlook for MMAe procedures?
Costa Rica facility's role in cost-effectiveness
Penumbra's PE tech differentiation post-STORM-PE
MMA embolization: future product enhancements or studies
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Penumbra earnings date

Logotype for Penumbra Inc
Q4 202523 Feb, 2026
Penumbra
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Penumbra earnings date

Logotype for Penumbra Inc
Q4 202523 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Penumbra Inc designs, develops, and markets medical devices for neurovascular and vascular conditions. Its products support treatments for stroke, peripheral embolization, and thrombectomy procedures, serving healthcare providers and hospitals worldwide. Penumbra operates within the healthcare and medical device sectors. The company is headquartered in Alameda, California, and its shares are listed on the NYSE.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage